Summary Successful treatment of ocular tumours by chemotherapy and radiotherapy is sometimes limited by the special nature of the eye. Improvement is needed to avoid enucleation. Previous studies using locally administered antineoplastic agents have given promising results in the treatment of experimental ocular melanoma and spontaneous lymphoma. Another approach is use of radiosensitizers to improve radiotherapeutic effect.
Ocular tumours present special problems in management due to sensitivity of the eye and its relative pharmacological isolation. Melanoma and retinoblastoma are the most common primary tumours in this location and the incidence of metastatic spread of solid tumours to the eye is increasing. There is considerable effort towards improvements in local control of disease by non-surgical methods. Chemotherapy and radiotherapy, the alternative methods of treatment, are not without complications. Local administration of antineoplastic drugs to the eye is being evaluated by us as a means of penetrating this pharmacological sanctuary. Absorption and pharmacokinetics after local administration of antineoplastic agents have been compared with the i.v. route in the rabbit eye (e.g. Rootman et al., 1983b; Rootman et al., 1984) . Effects on melanoma in rabbits (Rootman et al., submitted) , ocular leukaemia in humans (Rootman & Gudauskas, 1981) and lymphosarcoma in a cat (Rootman et al., 1983a) encourage further investigation of this direct route of administration. Related studies on absorption of nitroimidazole radiosensitizers were carried out (Rootman et al., 1982) because of their possible use in treatment of retinoblastoma, which contains hypoxic cells (Gallie et al., 1982) . Here, we examine drugs which may have both direct toxicity to, and/or increased radiosensitivity of, the resistant hypoxic fraction in tumours. For the initial study on tumoricidal effects, an implantable ocular melanoma described by Greene and Harvey (1966) was used to examine the following drugs:
(i) 5-thio-D-glucose -selected (Skov et al., 1984) because of its antitumour activity (Bushway & Whistler, 1975) ; low systemic toxicity (LD50 -5.5gkg-1) (Song et al., 1986) ; toxicity to and radiosensitization of hypoxic cells (Song et al., 1978 (Song et al., , 1980 and tumours (Markoe et al., 1980) ; protection of oxygenated (normal) cells against radiation damage (Schuman et al., 1982) ; and high uptake in animal tumour (Markoe et al., 1980b with radiation may be due to resulting interference with repair of DNA damage (Nagle et al., 1980) . (ii) Cis-platin -a successful antineoplastic agent which potentiates radiation damage in hypoxia (Douple & Richmond, 1979; Nias, 1985) . This interaction which is being exploited clinically (Coughlin et Rabbits were divided into 3 groups of 3 or 4 animals each: Group 1 received injection of drugs starting immediately after tumour implantation: (300mg 5TG or 400pg cis-platin in saline); Group 2 received the same subconjunctival injection of 5TG or cis-platin one week after the tumour implantation; Group 3 received saline and served as controls. Drugs were given twice a week for 17 days. Daily ocular examinations using a slit lamp were performed to monitor tumour growth. At the end of the experiment (17th day), the animals were sacrificed, eyes weighed and prepared for histological sectioning. Effectiveness of treatment was determined by comparison of weight of tumour in the treated groups with the control groups. These results were supported by histopathological means, and by photography to evaluate the size and extent of tumour invasion in the eye.
In vitro experiments CHO cells were used to study the toxicity and radiosensitizing ability of 5TG and cis-platin under hypoxic and oxic conditions. Radiobiological hypoxia is produced by flow of nitrogen for 30-45min over stirred suspension of cells. The methods used in this laboratory routinely (Moore et al., 1976) result in standard OER (2.8), hypoxic toxicity of misonidazole, etc.; however, to see toxicity of 5TG in hypoxic cells, higher cell densities (106ml-1) and/or incubation at 37°C was required to ensure a more complete depletion of oxygen than is needed in radiobiology (Schultz & Bongiorni, 1984) . Cis-platin on the other hand gives reproducible marked toxicity in both oxic and hypoxic cells under our standard conditions.
Results and discussion
Toxicity and absorption 5TG caused no severe reactions at relatively high doses and it was felt that repeated local administration of this drug would be possible. A dose of 400 mg in 0.5 ml was not exceeded due to solubility/viscosity of the drug. At this upper dose, the main clinical signs of toxicity were extreme conjunctival oedema and slight conjunctival hyperemia with moderate flare and cells in the anterior chambers. The maximum tolerable dose, 300mg in 0.5ml resulted in a peak concentration in the right aqueous of 5 mm at approximately one hour (Figure la) , with some absorption into the right vitreous, and into the left eye due to crossover. Relative bioavailabilities over 12 h for 5TG was 1,122 g h -1 and 244pgh-1 for the right and left anterior chambers respectively. 5TG clearance via body fluids is shown in Figure 2a . In vitro, considerable toxicity at this concentration can be The left eye (control) shows some absorption due to crossover from the injected (right) eye. measured in extremely hypoxic cells (Schultz & Bongiorni, 1984) . In CHO cells, we found a plating efficiency of 10-3 at 8h which is more than observed in radiobiological hypoxia (Song et al., 1977 (Song et al., , 1978 . Slight radiosensitization (E.R. -1.1) was produced by this concentration of 5TG in extremely hypoxic CHO cells.
The maximum tolerable dose of cis-platin was 400,pg in 0.5ml which resulted in a peak concentration of 0.68,pM in the right aqueous at 0.5h (Figure lb) . Levels in the vitreous were below detection limits (0.04pM). Bio-availabilities over 12h for cis-platin were 0.17gh -1 and 0.06pgh -1 for the right and left anterior chambers respectively. Platinum elimination is shown in Figure 2b . When the maximum tolerated doses of cis-platin were exceeded (500,pg, the Figure 1 ). Retinoblastoma contains hypoxic cells (Gallie et al., 1982) which are believed responsible, at least in part, for of drugs on Greene melanoma the failure of local control. Melanoma is reputed to be radioresistant, although this may need reassessment ntrol animals, the tumour grew rapidly: nodules (Harwood & Cummings, 1981) . Further evaluation of ocular *ed on the iris at -day 5, neovascularization and a melanoma for radiobiological studies is warranted and ied iris at -day 10, with perforation at the limbus at further studies of the interactions between drugs and 17. The tumour filled the anterior chamber and large radiation is planned using retinoblastoma and uveal )f necrosis were observed. melanoma cells in vitro. Tumours in the eyes of rabbits treated locally with 5TG commencing at the time of implantation were approximately half the size of controls ( Figure 3) ; those whose treatment began after one week did not show significant growth delay.
Some authors have seen an effect of 5TG on tumours (Markoe et al., 1980b; Song et al., 1980 ), yet others found no effect (Rockwell & Schultz, 1984; Tannock et al., 1983 
